Richtlijn Niercelcarcinoom

Conclusie
Niveau 1
TNM stadiëring heeft consequenties voor de prognose van het
niercelcarcinoom en kan derhalve van invloed zijn op de behandeling.
A2 Moch 2000, Gettman 2001, Amin 2002, Frank 2002, Ficarra 2002, Lau
2002, Cheville 2003, Leibovich 2003, Krejci 2003, Pantuck 2003,
Patard 2003, Bonsib 2004
Aanbeveling
Bij de stadiëring van het niercelcarcinoom moet de TNM 2002 of een recentere versie
worden toegepast.
Literatuur
Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, Peralta-Venturina M, et al. Prognostic
impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405
cases. Am.J.Surg.Pathol. 2002; 26[3], 281-291.
Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100
renal cell carcinomas. Am J Surg Pathol. 2004 Dec;28(12):1594-600
Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and
prognostic features among histologic subtypes of renal cell carcinoma. Am.J.Surg.Pathol.
2003; 27[5], 612-624
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction
model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based
on tumor stage, size, grade and necrosis: the SSIGN score. J.Urol. 200;2 168[6], 2395-2400.
Ficarra V, Righetti R, Pilloni S, D'amico A, Maffei N, Novella G, et al. Prognostic factors in
patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur.Urol. 2002; 41[2],
190-198
Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H. Pathologic staging of renal cell
carcinoma: significance of tumor classification with the 1997 TNM staging system. Cancer
2001; 91[2], 354-361
Hsu RM, Chan DY, Siegelman SS. Small renal cell carcinomas: correlation of size with tumor
stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol. 2004 Mar;182(3):551-7
Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H. Nephron-sparing surgery
for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology
2003; 62[4], 641-646.
Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H. Prognostic features of pathologic
stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002; 59[4], 532-537
Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, et al. Scoring algorithm to
predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell
carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 98[12], 2566-2575
Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the
recently recommended histologic classification and revised TNM staging system of renal cell
carcinoma: a Swiss experience with 588 tumors. Cancer 2000; 89[3], 604-614
Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, et al. Renal cell carcinoma with
retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer
2003; 97[12], 2995-3002
Patard JJ, Leray E, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B. Correlation between
symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol.
2003 Aug;44(2):226-32
42